International Journal of Endocrinology
Volume 2015 (2015), Article ID 158758, 8 pages
http://dx.doi.org/10.1155/2015/158758

Research Article

Insulin Resistance of Normal Weight Central Obese Adolescents in Korea Stratified by Waist to Height Ratio: Results from the Korea National Health and Nutrition Examination Surveys 2008–2010

Won Kyoung Cho,¹ Hyojin Kim,¹ Hyun Young Lee,¹ Kyung Do Han,² Yeon Jin Jeon,¹ In Ah Jung,¹ Shin Hee Kim,¹ Kyoung Soon Cho,¹ So Hyun Park,¹ Min Ho Jung,¹ and Byung-Kyu Suh¹

¹Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea
²Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea

Received 13 May 2015; Accepted 8 July 2015

Academic Editor: Marek Bolanowski

Copyright © 2015 Won Kyoung Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. To evaluate insulin resistance of normal weight central obese 13–18-year-old male and female adolescents stratified by waist to height ratio (WHR). Methods. Data were obtained from the Korea National Health and Nutrition Examination Survey (K-NHANES) conducted during 2008–2010. Central obesity was defined as that in the upper quartile of age and sex specific WHR. Subjects were classified into no central obesity normal weight (NW), central obesity normal weight (CONW), no central obesity overweight (OW), and central obesity overweight (COOW). Results. The prevalence of CONW was 9.6% (83/832) in female and 7.0% (61/909) in male. CONW showed higher levels of insulin (), HOMA-IR (), and ALT () than NW in female. CONW had higher levels of insulin (), HOMA-IR (), and WBC count () and lower level of HDL () than NW in male. WHR and BMI had similar significant correlations with MS components. CONW showed 2.5 times (95% confidence interval, 1.21–5.00) more likelihood to have high insulin resistance than NW in male. Conclusions. Screening for central obesity using WHR in clinical setting is recommended.

1. Introduction

The prevalence of childhood obesity has significantly increased worldwide and has become an important global public health issue [1]. Childhood obesity is a risk factor for cardiovascular disease and metabolic syndrome (MS) in adulthood and thus affects morbidity and mortality in later life [2]. Adipose tissue in the visceral fat has been considered a major contributing factor in insulin resistance as well as a risk of type 2 diabetes and coronary heart disease [3–5]. The World Health Organization (WHO) defines obesity as an excessive accumulation of fat to an extent that health may be impaired [6]. The most commonly used anthropometric tool to classify obesity is body mass index (BMI) [7]. However, BMI cannot distinguish between lean and fat mass [7, 8].

Recently, recognition of different subtypes of obesity including metabolically healthy but obese individuals and metabolically obese but normal weight individuals has been reported [9]. This suggests that individuals should not be classified as obese based solely on BMI. Indeed, a substantial proportion of BMI-defined normal weight showed cardiometabolic abnormalities that puts them at increased risk for future development of obesity-related diseases [8]. A previous study suggested that abdominal obesity may indicate higher cardiovascular disease risks even in normal weight women [10]. Therefore, screening for abdominal obesity in adolescents with normal weight is an important contribution to the prevention of obesity related disease.

Waist to height ratio (WHR) has been reported to be useful in screening for cardiovascular risk factor in children and adolescents [11–14]. This measure is easier to calculate than BMI, does not require tables, and can be used to diagnose visceral obesity, even in normal weight individuals [15]. WHR incorporates waist circumference as a measure of abdominal obesity and adjusts for an individual’s size by dividing their height [16]. It combines the advantages of both BMI and waist to hip ratio by accounting for height and abdominal adiposity [17]. WHR further specifies cardiometabolic risk based on BMI percentile [18].

There are no reports of the characteristics or prevalence of subjects who are of normal weight by BMI but having central obesity when stratified by WHR in Korean adolescents. The aim of this study is to investigate the metabolic characteristics in Korean adolescents with central obesity but normal weight by BMI.

2. Methods

2.1. Data

Data were obtained from the Korea National Health and Nutrition Examination Surveys (K-NHANES) conducted from 2008 to 2010 by the Korean Ministry of Health and Welfare. K-NHANES is a cross-sectional survey based on stratified multistage probability samples of Korean households representing the civilian noninstitutionalized population. More details regarding study design and methods are provided elsewhere [19]. The K-NHANES data are publicly available; thus, this study did not require approval from the institutional review board.

2.2. Selection of Study Populations

Overall, 2280 subjects aged 13–18 years participated in the 2008–2010 K-NHANES. Among them, 411 participants were excluded due to incomplete information about anthropometric data (height and weight) and laboratory data. Of these 1869 subjects, 128 having below 5th percentile of BMI according to age and sex were excluded. Ultimately, our study population included 1741 adolescents (male = 909, female = 832).

2.3. Anthropometric and Laboratory Measurements

Height was measured using a stadiometer (SECA, Hamburg, Germany), and weight was measured with a balance beam scale (GL-6000-20, CASKOREA, Korea) while participants were wearing a standardized gown. Waist circumference (WC) was measured to the nearest 0.1 cm at the end of normal expiration, measuring from the narrowest point at the midline of the most lateral border of the right and left ileac crest [19]. Fasting plasma concentrations of glucose, insulin, triglyceride (TG), and high density lipoprotein (HDL), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were measured enzymatically using a Hitachi 747 chemistry analyzer (Daiichi, Tokyo, Japan) after subjects had participated in a minimum 8-hour overnight fast. White blood cell (WBC) count was obtained using XE-2100D (Sysmex, Kobe, Japan). Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated as fasting glucose (in millimoles per liter) × fasting insulin (in milliunits per liter)/22.5, while blood pressure (BP) was calculated as the mean of three successive readings using a standard mercury sphygmomanometer (Baumanometer). Mean arterial pressure was also calculated.

2.4. Study Criteria

A subject was first classified as normal weight (5th–85th percentiles) or overweight (include obesity, ≥85th percentile) by BMI according to 2007 Korea Growth Charts [20]. There was no confirmed cut-off value of WHR for health risks of obesity in adolescents. So we defined the central obesity as those in the upper highest quartile (Q4) of age and sex specific WHR and the no central obesity as those below the highest quartile (Q1, Q2, and Q3) of WHR. Following these criteria, body composition groups were further classified into no central obesity normal weight (NW), central obesity normal weight (CONW), no central obesity overweight (OW), and central obesity overweight (COOW). We defined subjects as having high insulin resistance if they were in the upper highest quartile (Q4) according to age and sex of HOMA-IR measurements.

2.5. Statistical Analyses

All statistical analyses were performed using SAS Version 9.3 (SAS Institute Inc., Cary, NC). Sampling weights were incorporated to produce valid population estimates that accounted for the complex survey design of K-NHANES. Data are presented as mean ± standard error (SE) for continuous variables and frequency percentage for categorical variables. If necessary, logarithmic transformation was performed to achieve a normal distribution. The characteristics and laboratory data of body composition groups by sex were compared using ANOVA for continuous measures and chi-squared tests for categorical measures. Bonferroni corrections were used to assess the significance between 4 groups. Pearson’s correlation coefficients between WHR or BMI and various parameters of the insulin resistance syndrome were calculated. Multivariate logistic regression models were used to compare the adjusted odds ratio (OR) and 95% confidence interval (CI) of having high insulin resistance among body composition groups after adjusting for potentially confounding variables. Multivariate analyses of the adjusted ORs of having high insulin resistance were first adjusted for age (model 1) and then age plus weight (model 2). Model 3 was adjusted for the variables in model 2 plus ALT. Results with value less than 0.05 were considered significant.

3. Results

3.1. The Prevalence of NW, CONW, OW, COOW, and Overweight in 13–18-Year-Old Korean Adolescents

The prevalence of NW was 72.7% (604/832), CONW was 9.6% (83/832), OW was 2.5% (20/832), and COOW was 15.1% (125/832) in female adolescents. In male adolescents, the prevalence of NW was 72.3% (662/909), CONW was 7.0% (61/909), OW was 2.2% (21/909), and COOW was 18.5% (165/909). The prevalence of overweight (include obesity) was 20.7% in male and 17.6% in female in 13–18-year-old 1741 Korean adolescents (subjects below 5th percentile of BMI were excluded) (Tables 1 and 2). When subjects below 5th percentile of BMI were included, the prevalence of overweight (include obesity) was 17.6% in male and 15.1% in female in 13–18-year-old 2280 Korean adolescents using the data from 2008–2010 K-NHANES (data not shown).

Table 1: Subject characteristics and laboratory data according to four body composition groups in 13–18-year-old female adolescents.

Female
Normal weight (BMI 5th to 85th)
value
Overweight (BMI over 85th)
value
value

NW
CONW
OW
COOW

604 (72.7%)
83 (9.6%)
NW versus CONW
20 (2.5%)
125 (15.1%)
OW versus COOW
Among groups

Age (years)
15.4 ± 0.1
15.4 ± 0.2
0.879
15.6 ± 0.4
15.3 ± 0.2
0.579
0.945

Height (cm)
160.5 ± 0.3
158.7 ± 1
0.074
161.9 ± 0.8
160.8 ± 0.5
0.227
0.082

Weight (kg)
50.8 ± 0.2
54.9 ± 1.0
<0.0001
65.1 ± 1.2
68.6 ± 1
<0.022
<0.0001

BMI (kg/m²)
19.7 ± 0.1
21.7 ± 0.2
<0.0001
24.8 ± 0.3
26.5 ± 0.3
<0.0001
<0.0001

WC (cm)
65.8 ± 0.2
75.1 ± 0.6
<0.0001
71.3 ± 0.6
81 ± 0.7
<0.0001
<0.0001

WHR
41 ± 0.1
47.3 ± 0.2
<0.0001
44.0 ± 3.0
50.4 ± 0.4
<0.0001
<0.0001

SBP (mmHg)
101.8 ± 0.5
102.1 ± 1.4
0.813
102.2 ± 2.8
105.7 ± 1
0.242
<0.006

DBP (mmHg)
65.7 ± 0.4
64.7 ± 1.2
0.374
66.6 ± 2
66.7 ± 1
0.953
0.568

Glucose (mg/dL)
87.5 ± 0.3
88 ± 0.7
0.401
87.5 ± 1.2
89.9 ± 0.8
0.081
<0.028

Insulin (μU/mL)
11.4 (11–11.8)
12.9 (11.9–13.9)
<0.006
14.3 (12.0–17.1)
16 (14.5–17.7)
0.272
<0.0001

HOMA-IR
2.5 (2.4–2.5)
2.8 (2.6–3)
<0.006
3.1 (2.6–3.7)
3.5 (3.2–3.9)
0.201
<0.0001

TG (mg/dL)
71.6 (68.7–74.7)
77.5 (69.5–86.6)
0.186
77.3 (59.2–100.9)
89 (80.0–99.1)
0.344
<0.002

HDL (mg/dL)
56.4 ± 0.5
54.6 ± 1.5
0.284
50.8 ± 2.1
49.4 ± 1.2
0.563
<0.0001

TG/HDL
1.3 (1.2–1.4)
1.5 (1.3–1.7)
0.121
1.5 (1.2–2.1)
1.8 (1.6–2.1)
0.285
<0.0001

ALT (U/L)
10 (9.7–10.3)
11.5 (10.8–12.3)
<0.001
11.8 (9.9–14.1)
12.9 (11.6–14.3)
0.392
<0.0001

AST (U/L)
16 (15.7–16.3)
15.6 (14.8–16.5)
0.458
15.6 (13.9–17.5)
15.8 (15.3–16.4)
0.839
0.861

WBC (10⁹/L)
5.9 (5.8–6)
6.1 (5.7–6.6)
0.260
6.3 (5.7–7.0)
6.7 (6.4–7.0)
0.351
<0.0001

Data are presented as the means ± standard error (SE), geometric mean (95% CI), or % (SE).

Insulin, HOMA-IR, TG, TG/HDL, ALT, AST, and WBC count were tested after logarithmic transformation.

NW, no central obesity normal weight; CONW, central obesity normal weight; OW, no central obesity overweight; COOW, central obesity overweight; WC, waist circumstance; WHR, waist to height ratio; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; TG, triglyceride; HDL, high-density lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC, white blood cell.

Table 2: Subject characteristics and laboratory data according to four body composition groups in 13–18-year-old male adolescents.

Male
Normal weight (BMI 5th to 85th)
value
Overweight (BMI over 85th)
value
value

NW
CONW
OW
COOW

662 (72.3%)
61 (7.0%)
NW versus CONW
21 (2.2%)
165 (18.5%)
OW versus COOW
Among groups

Age (years)
15.5 ± 0.1
15.3 ± 0.3
0.464
16.3 ± 0.4
15.5 ± 0.1
0.044
0.107

Height (cm)
171.6 ± 0.3
169.1 ± 1.4
0.099
176.9 ± 1.2
172.1 ± 0.6
<0.001
<0.0001

Weight (kg)
59.9 ± 0.4
68 ± 1.2
<0.0001
79.5 ± 1.2
81.8 ± 1
0.157
<0.0001

BMI (kg/m²)
20.3 ± 0.1
23.7 ± 0.1
<0.0001
25.4 ± 0.1
27.5 ± 0.2
<0.0001
<0.0001

WC (cm)
70.1 ± 0.3
82.2 ± 0.6
<0.0001
80.2 ± 1
88.6 ± 0.7
<0.0001
<0.0001

WHR
40.9 ± 0.1
48.7 ± 0.3
<0.0001
45.3 ± 0.4
51.4 ± 0.4
<0.0001
<0.0001

SBP (mmHg)
108 ± 0.5
110.4 ± 1.3
0.075
110.6 ± 2.4
115.8 ± 1.1
0.050
<0.0001

DBP (mmHg)
67.7 ± 0.4
65.7 ± 1.1
0.101
69.6 ± 1.6
70.7 ± 0.9
0.526
<0.002

Glucose (mg/dL)
88.6 ± 0.3
89.1 ± 1.1
0.642
91.2 ± 2.1
90.4 ± 0.6
0.702
<0.034

Insulin (μU/mL)
10.6 (10.3–11)
13.6 (12.3–15.1)
<0.0001
15.1 (12.3–18.5)
17.4 (16.0–18.8)
0.210
<0.0001

HOMA-IR
2.3 (2.3–2.4)
3 (2.7–3.3)
<0.0001
3.4 (2.7–4.3)
3.9 (3.6–4.2)
0.288
<0.0001

TG (mg/dL)
70.4 (67.4–73.5)
76.2 (64.0–90.8)
0.386
73.6 (56.3–96.2)
114 (101.5–127.9)
<0.003
<0.0001

HDL (mg/dL)
51.8 ± 0.4
47 ± 1.1
<0.0001
52.6 ± 2.9
45.7 ± 0.7
<0.022
<0.0001

TG/HDL
1.4 (1.3–1.4)
1.6 (1.3–2.0)
0.101
1.4 (1.0–2.0)
2.5 (2.2–2.9)
<0.003
<0.0001

ALT (U/L)
12.8 (12.3–13.4)
17 (15.3–18.8)
<0.0001
22.8 (15.0–34.8)
24.8 (22.3–27.7)
0.704
<0.0001

AST (U/L)
17.9 (17.5–18.4)
18.6 (17.5–19.8)
0.272
20.1 (16.6–24.5)
21 (19.9–22.1)
0.698
<0.0001

WBC (10⁹/L)
6 (5.9–6.1)
6.4 (6.1–6.8)
<0.021
6.5 (6.1–6.9)
6.8 (6.5–7.0)
0.257
<0.0001

Data are presented as the means ± standard error (SE), geometric mean (95% CI), or % (SE).

Insulin, HOMA-IR, TG, TG/HDL, ALT, AST, and WBC count were tested after logarithmic transformation.

NW, no central obesity normal weight; CONW, central obesity normal weight; OW, no central obesity overweight; COOW, central obesity overweight; WC, waist circumstance; WHR, waist to height ratio; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; TG, triglyceride; HDL, high density lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC, white blood cell.

3.2. Characteristic and Laboratory Data according to Four Body Composition Groups in 13–18-Year-Old Korean Adolescents

In female adolescents, CONW showed higher mean levels of weight ( versus , ), BMI ( versus , ), WC ( versus , ), WHR ( versus , ), insulin [11.4 (11–11.8) versus 12.9 (11.9–13.9), ], HOMA-IR [2.5 (2.4–2.5) versus 2.8 (2.6–3.0), ], and ALT [10.0 (9.7–10.3) versus 11.5 (10.8–12.3), ] than NW. COOW showed higher mean levels of weight, BMI, WC, and WHR than OW (Table 1).

In male adolescents, CONW showed higher mean levels of weight ( versus , ), BMI ( versus , ), WC ( versus , ), WHR ( versus , ), insulin [10.6 (10.3–11.0) versus 13.6 (12.3–15.1), ], HOMA-IR [2.3 (2.3–2.4) versus 3.0 (2.7–3.3), ], ALT [12.8 (12.3–13.4) versus 17.0 (15.3–18.8), ], and WBC count [6.0 (5.9–6.1) versus 6.4 (6.1–6.8), ] and lower mean level of HDL ( versus , ) than NW. COOW had higher mean levels of BMI, WC, WHR, TG, and TG/HDL ratio and lower mean level of HDL than OW (Table 2). In both male and female adolescents, there were no significant differences in MS components between CONW and OW (data not shown).

3.3. Correlations between WHR or BMI and MS Components in 13–18-Year-Old Korean Adolescents

In female adolescents, WHR showed significant positive correlations with BMI (, ), SBP (, ), insulin (, ), HOMA-IR (, ), TG (, ), TG/HDL (, ), ALT (, ), and WBC (, ) and showed significant negative correlations with HDL (, ). BMI showed significant positive correlations with SBP (, ), insulin (, ), HOMA-IR (, ), TG (, ), TG/HDL (, ), ALT (, ), and WBC (, ) and showed significant negative correlations with HDL (, ).

In male adolescents, WHR showed significant positive correlations with BMI (, ), SBP (, ), insulin (, ), HOMA-IR (, ), TG (, ), TG/HDL (, ), ALT (, ), and WBC (, ) and showed significant negative correlations with HDL (, ). BMI showed significant positive correlations with SBP (, ), insulin (, ), HOMA-IR (, ), TG (, ), TG/HDL (, ), ALT (, ), AST (, ), and WBC (, ) and showed significant negative correlation with HDL (, ) (Table 3).

Table 3: Correlations between WHR or BMI and metabolic syndrome components in 13–18-year-old male and female adolescents.

Female
Male

WHR
BMI
WHR
BMI

value

value

value

value

BMI
0.84
<0.0001

0.91
<0.0001

SBP (mmHg)
0.18
<0.0001
0.18
<0.0001
0.27
<0.0001
0.33
<0.0001

DBP (mmHg)
−0.01
0.916
0.05
0.412
0.11
0.023
0.19
<0.0001

Glucose (mg/dL)
0.11
0.085
0.12
0.072
0.08
0.048
0.07
0.071

Insulin (μU/mL)
0.30
<0.0001
0.33
<0.0001
0.49
<0.0001
0.48
<0.0001

HOMA-IR
0.30
<0.0001
0.32
<0.0001
0.47
<0.0001
0.46
<0.0001

TG (mg/dL)
0.17
<0.0001
0.16
<0.0001
0.32
<0.0001
0.31
<0.0001

HDL (mg/dL)
−0.22
<0.0001
−0.23
<0.0001
−0.27
<0.0001
−0.27
<0.0001

TG/HDL
0.22
<0.0001
0.22
<0.0001
0.35
<0.0001
0.34
<0.0001

ALT (U/L)
0.32
<0.0001
0.33
<0.0001
0.53
<0.0001
0.52
<0.0001

AST (U/L)
−0.004
0.919
−0.02
0.643
0.24
<0.0001
0.19
<0.0001

WBC (10⁹/L)
0.16
<0.0001
0.19
<0.0001
0.26
<0.0001
0.27
<0.0001

Data are presented as the means ± standard error (SE), geometric mean (95% CI), or % (SE).

Insulin, HOMA-IR, TG, TG/HDL, ALT, AST, and WBC count were tested after logarithmic transformation.

WHR, waist to height ratio; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; TG, triglyceride; HDL, high density lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC, white blood cell.

3.4. Correlations between WHR and MS Components of Normal and Overweight 13–18-Year-Old Korean Adolescents

In normal weight female adolescents, WHR exhibited a significant positive correlation with BMI (, ), insulin (, ), HOMA-IR (, ), TG/HDL ratio (, ), and ALT (, ) and a significant negative correlation with HDL (, ). In overweight female adolescents, WHR showed significant positive correlations with BMI (, ), SBP (, ), insulin (, ), HOMA-IR (, ), and ALT (, ).

In normal weight male adolescents, WHR showed a significant positive correlation with BMI (, ), SBP (, ), insulin (, ), HOMA-IR (, ), TG/HDL ratio (, ), ALT (, ), and WBC (, ) and a significant negative correlation with HDL (, ). In overweight male adolescents, WHR showed significant positive correlations with BMI (, ), insulin (, ), HOMA-IR (, ), TG (, ), TG/HDL ratio (, ), ALT (, ), AST (, ), and WBC (, ) and a significant negative correlation with HDL (, ) (Table 4).

Table 4: Correlations between WHR and metabolic syndrome components of normal and overweight 13–18-year-old male and female adolescents.

Female
Male

Normal weight
Overweight
Normal weight
Overweight

(BMI 5th to 85th)
(BMI over 85th)
(BMI 5th to 85th)
(BMI over 85th)

value

value

value

value

BMI
0.67
<0.0001
0.75
<0.0001
0.80
<0.0001
0.84
<0.0001

SBP (mmHg)
0.05
0.271
0.30
<0.001
0.10
<0.018
0.15
0.133

DBP (mmHg)
−0.08
0.063
0.06
0.516
−0.03
0.555
0.12
0.274

Glucose (mg/dL)
−0.02
0.557
0.21
0.160
0.01
0.772
−0.04
0.648

Insulin (μU/mL)
0.10
<0.014
0.24
<0.006
0.27
<0.0001
0.26
<0.001

HOMA-IR
0.08
<0.025
0.26
<0.002
0.29
<0.0001
0.24
<0.003

TG (mg/dL)
0.07
0.059
0.12
0.145
0.10
0.064
0.23
<0.005

HDL (mg/dL)
−0.10
<0.017
−0.10
0.229
−0.17
<0.0001
−0.17
<0.036

TG/HDL
0.10
<0.015
0.13
0.073
0.140
<0.008
0.23
<0.005

ALT (U/L)
0.23
<0.0001
0.19
<0.034
0.32
<0.0001
0.33
<0.0001

AST (U/L)
−0.01
0.839
0.07
0.483
0.07
0.179
0.27
<0.0007

WBC (10⁹/L)
0.06
0.156
0.10
0.198
0.15
<0.001
0.17
<0.038

Data are presented as the means ± standard error (SE), geometric mean (95% CI), or % (SE).

Insulin, HOMA-IR, TG, TG/HDL, ALT, AST, and WBC count were tested after logarithmic transformation.

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; TG, triglyceride; HDL, high density lipoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC, white blood cell.

3.5. Multivariate Logistic Regression Analyses of Having High Insulin Resistance among Body Composition Groups

In female adolescents, there was no significant difference in odds ratio of having upper highest quartile of age and sex specific HOMA-IR between NW and CONW or OW (model 3). Only COOW was 2.1 times (95% confidence interval [CI], 1.1–4.2) more likely to have high insulin resistance than NW after adjusting age, weight, and ALT (model 3).

In male adolescents, CONW was 2.5 times (95% CI, 1.2–5.0) more likely to have high insulin resistance than NW (model 3). However, there was no significant difference in odds ratio of having high insulin resistance between OW and NW. And COOW was 2.4 times (95% CI, 1.2–4.7) more likely to have high insulin resistance than NW after adjusting age, weight, and ALT (model 3) (Table 5).

Table 5: Multivariate logistic regression analyses of having high insulin resistance among body composition groups.

Model 1: adjusted for age
Model 2: adjusted for age and weight
Model 3: adjusted for age, weight, and ALT

OR
95% CI
value
OR
95% CI
value
OR
95% CI
value

Female

Group

<0.0001

0.118

0.151

    NW
1

1

1

    CONW
1.89
1.04–3.42

1.54
0.85–2.78

1.51
0.83–2.75

    OW
3.09
1.22–7.85

1.56
0.55–4.41

1.55
0.54–4.44

    COOW
5.09
3.21–8.10

2.14
1.09–4.20

2.11
1.06–4.18

Age
0.97
0.87–1.09
0.653
0.91
0.81–1.03
0.131
0.91
0.81–1.03
0.128

Weight

1.05
1.02–1.09
<0.003
1.05
1.02–1.09
<0.004

ALT

1.23
0.73–2.06
0.440

Male

Group

<0.0001

<0.002

<0.022

    NW
1

1

1

    CONW
4.37
2.32–8.22

2.82
1.38–5.75

2.46
1.21–4.99

    OW
8.29
2.43–28.22

3.29
0.90–11.98

2.57
0.78–8.49

    COOW
10.08
6.69–15.20

3.25
1.60–6.59

2.38
1.20–4.70

Age
0.99
0.89–1.11
0.873
0.85
0.73–0.99
<0.045
0.82
0.70–0.95
<0.007

Weight

1.06
1.03–1.09
<0.0001
1.05
1.03–1.08
<0.0001

ALT

2.14
1.46–3.15
<0.0001

HOMA-IR, homeostasis model assessment-insulin resistance; CI, confidential interval; NW, no central obesity normal weight; CONW, central obesity normal weight; OW, no central obesity overweight; COOW, central obesity overweight; ALT, alanine aminotransferase.

4. Discussion

In the present study, we found that 9.6% of female and 7.0% of male are CONW which are classified as normal weight by BMI. In adult male and female of different ethnic groups, the cut-off value of WHR for health risks of obesity was 0.5 [14]. Since the height and waist circumference of children increases continually as they age, some reports suggest 0.5 could be a cut-off value of WHR for health risks of obesity in children [16, 21, 22]. However, there was no confirmed cut-off value of WHR for health risks of obesity in adolescents. The subjects in our study were aged 13–18 years and not homogenous in terms of the degree of maturation. Data from K-NHANES did not include information about sexual maturation rate. For adjusting heterogeneity in terms of the degree of maturation, we classified central obesity as that in the age and sex specific upper highest quartile (Q4) of WHR. Asians are known to have higher amounts of visceral adipose tissue than Caucasians [23]. Our results can be due to the impact of ethnicity. It is recommended to assess and compare the prevalence CONW using universal cut-off value of WHR for health risks of obesity in multiple ethnic adolescents in the near future.

In this study, the prevalence of overweight (include obesity) was 20.7% in male and 17.6% in female in 13–18-year-old 1741 Korean adolescents (those below 5th percentile of BMI were excluded). Our data on the prevalence of overweight (include obesity) were similar to the previous reports [24, 25]. Overall, about 30% of American adolescents and 25% of European adolescents were overweight or obese [26]. The prevalence of overweight in Korean adolescents was lower than America and Europe. However, the prevalence of obesity increased from 6.1% in 1997 to 11.3% in 2005 in boys and increased from 5.5% in 1997 to 8.0% in 2005 in girls [27].

We found that CONW showed poor MS components compared to NW and no significant difference in MS components compared to OW in both male and female adolescents. Metabolically obese but normal weight individuals were first described by Ruderman et al. [28]. A central obese but normal weight individuals who increased risks for MS has been reported [8, 29–31]. In Korean adults, high prevalence of cardiometabolic abnormalities among subjects with normal weight having central obesity was previously reported [32]. Our results suggest that more medical concerns for CONW classified normal weight by BMI are necessary even in adolescents.

We found that WHR and BMI had similar significant correlations with SBP, insulin, HOMA-IR, TG, TG/HDL, ALT, WBC, and HDL in Korean adolescents. WHR is recommended as an effective and precise anthropometric index to assess visceral adiposity and to predict insulin resistance [33]. Excess visceral fat is associated with high impaired suppression of free fatty acid (FFA) release and insulin resistance in muscle and liver [34, 35]. These results may suggest that WHR is comparable to BMI in predicting MS components in Korean adolescents.

In male, CONW was 2.5 times more likely to have high insulin resistance than NW after adjusting for age, weight, and ALT. This finding indicates that insulin resistance can be present even in adolescents classified as normal weight by BMI. However, the odds ratio having high insulin resistance of CONW than NW was not significant in female Korean adolescents. This result was inconsistent with previous report of other ethnic adolescents. Some report suggests that intra-abdominal obesity is associated with adverse cardiovascular risk factor in both male and female adolescents [36]. Other reports showed that central obesity index was only associated with insulin resistance in only female obese Caucasian adolescents [37]. Women have more subcutaneous fat, whereas men have more visceral fat which is already previously reported. However, there was no significant difference in visceral fat between female and male adolescents [38]. Visceral adipose tissue carries a greater risk for cardiovascular disorders than does subcutaneous adipose tissue [39]. Subcutaneous fat mass is associated with protective lipid and glucose profiles, as well as decreased cardiovascular and metabolic risks. Indeed, WHR may have difficulty in discriminating subcutaneous and visceral adipose tissue. The difference between male and female adolescents in our results may be explained by sexual dimorphism in body fat distribution or ethnic/race factors.

To the best of our knowledge, this is the first study to show that CONW have higher insulin resistance than NW particularly in Korean male adolescents. WHR can discover CONW not found by BMI. WHR is comparable to BMI in assessing MS components and is a good index for detecting insulin resistance even in normal weight male adolescents. Further researches to establish more appropriate cut-off value of WHR for health risks of obesity and the sexual dimorphism in body fat distribution on insulin resistance in adolescents are necessary. Screening for central obesity using WHR in clinical setting is recommended.

Conflict of Interests

There was no conflict of interests.

References

T. Lob-Corzilius, “Overweight and obesity in childhood—a special challenge for public health,” International Journal of Hygiene and Environmental Health, vol. 210, no. 5, pp. 585–589, 2007.

R. Weiss and S. Caprio, “The metabolic consequences of childhood obesity,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 19, no. 3, pp. 405–419, 2005.

P. Patel and N. Abate, “Body fat distribution and insulin resistance,” Nutrients, vol. 5, no. 6, pp. 2019–2027, 2013.

A. De Lorenzo, V. Del Gobbo, M. G. Premrov, M. Bigioni, F. Galvano, and L. Di Renzo, “Normal-weight obese syndrome: early inflammation?” The American Journal of Clinical Nutrition, vol. 85, no. 1, pp. 40–45, 2007.

M. Vanhala, “Childhood weight and metabolic syndrome in adults,” Annals of Medicine, vol. 31, no. 4, pp. 236–239, 1999.

WHO, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, vol. 894 of World Health Organization Technical Report Series, 2000.

M. Bastien, P. Poirier, I. Lemieux, and J.-P. Després, “Overview of epidemiology and contribution of obesity to cardiovascular disease,” Progress in Cardiovascular Diseases, vol. 56, no. 4, pp. 369–381, 2014.

J. L. Shea, M. T. C. King, Y. Yi, W. Gulliver, and G. Sun, “Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 9, pp. 741–747, 2012.

A. D. Karelis, D. H. St-Pierre, F. Conus, R. Rabasa-Lhoret, and E. T. Poehlman, “Metabolic and body composition factors in subgroups of obesity: what do we know?” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2569–2575, 2004.

S. Kwon, “Association between abdominal obesity and cardiovascular risk factors in normal-weight Korean women,” Health Care for Women International, vol. 30, no. 5, pp. 447–452, 2009.

W. Yan, H. Bingxian, Y. Hua et al., “Waist-to-height ratio is an accurate and easier index for evaluating obesity in children and adolescents,” Obesity, vol. 15, no. 3, pp. 748–752, 2007.

S. C. Savva, M. Tornaritis, M. E. Savva et al., “Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index,” International Journal of Obesity and Related Metabolic Disorders, vol. 24, no. 11, pp. 1453–1458, 2000.

S. Nambiar, H. Truby, P. S. Davies, and K. Baxter, “Use of the waist-height ratio to predict metabolic syndrome in obese children and adolescents,” Journal of Paediatrics and Child Health, vol. 49, no. 4, pp. E281–E287, 2013.

M. Ashwell and S. D. Hsieh, “Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity,” International Journal of Food Sciences and Nutrition, vol. 56, no. 5, pp. 303–307, 2005.

V. M. Kuba, C. Leone, and D. Damiani, “Is waist-to-height ratio a useful indicator of cardio-metabolic risk in 6–10-year-old children?” BMC Pediatrics, vol. 13, no. 1, article 91, 2013.

I. de Pauda Cintra, M. A. Z. Passos, L. C. dos Santos, H. D. C. Machado, and M. Fisberg, “Waist-to-height ratio percentiles and cutoffs for obesity: a cross-sectional study in Brazilian adolescents,” Journal of Health, Population and Nutrition, vol. 32, no. 3, pp. 411–419, 2014.

J. S. Mokha, S. R. Srinivasan, P. DasMahapatra et al., “Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart study,” BMC Pediatrics, vol. 10, article 73, 2010.

M. Khoury, C. Manlhiot, and B. W. McCrindle, “Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index,” Journal of the American College of Cardiology, vol. 62, no. 8, pp. 742–751, 2013.

Korea Centers for Disease Control and Prevention, “Korean national health and nutrition examination survey,” July 2013, http://knhanes.cdc.go.kr/

J. S. Moon, S. Y. Lee, C. M. Nam et al., “2007 Korean National Growth Charts: review of developmental process and an outlook,” Korean Journal of Pediatrics, vol. 51, no. 1, pp. 1–25, 2008.

H. D. McCarthy and M. Ashwell, “A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message—‘keep your waist circumference to less than half your height’,” International Journal of Obesity, vol. 30, no. 6, pp. 988–992, 2006.

S. Nambiar, I. Hughes, and P. S. Davies, “Developing waist-to-height ratio cut-offs to define overweight and obesity in children and adolescents,” Public Health Nutrition, vol. 13, no. 10, pp. 1566–1574, 2010.

C.-H. Wu, S. Heshka, J. Wang et al., “Truncal fat in relation to total body fat: influences of age, sex, ethnicity and fatness,” International Journal of Obesity, vol. 31, no. 9, pp. 1384–1391, 2007.

J. Park, D. C. Hilmers, J. A. Mendoza, J. E. Stuff, Y. Liu, and T. A. Nicklas, “Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea,” Journal of Korean Medical Science, vol. 25, no. 1, pp. 75–82, 2010.

H. Lim, H. Xue, and Y. Wang, “Association between obesity and metabolic co-morbidities among children and adolescents in South Korea based on national data,” BMC Public Health, vol. 14, no. 1, article 279, 2014.

M. del Mar Bibiloni, A. Pons, and J. A. Tur, “Prevalence of overweight and obesity in adolescents: a systematic review,” ISRN Obesity, vol. 2013, Article ID 392747, 14 pages, 2013.

K. Oh, M. J. Jang, N. Y. Lee et al., “Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005,” Korean Journal of Pediatrics, vol. 51, no. 9, pp. 950–955, 2008.

N. Ruderman, D. Chisholm, X. Pi-Sunyer, and S. Schneider, “The metabolically obese, normal-weight individual revisited,” Diabetes, vol. 47, no. 5, pp. 699–713, 1998.

A. De Lorenzo, R. Martinoli, F. Vaia, and L. Di Renzo, “Normal weight obese (NWO) women: an evaluation of a candidate new syndrome,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 8, pp. 513–523, 2006.

A. Romero-Corral, V. K. Somers, J. Sierra-Johnson et al., “Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality,” European Heart Journal, vol. 31, no. 6, pp. 737–746, 2010.

T. You, A. S. Ryan, and B. J. Nicklas, “The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5517–5522, 2004.

M. Kim, K. Han, H.-S. Kwon et al., “Normal weight obesity in Korean adults,” Clinical Endocrinology (Oxford), vol. 80, no. 2, pp. 214–220, 2014.

M. I. Barreto Silva, C. C. D. S. Lemos, M. R. S. G. Torres, and R. Bregman, “Waist-to-height ratio: an accurate anthropometric index of abdominal adiposity and a predictor of high HOMA-IR values in nondialyzed chronic kidney disease patients,” Nutrition, vol. 30, no. 3, pp. 279–285, 2014.

S. Y. Lim, H. S. Ha, H. S. Kwon et al., “Factors associated with insulin resistance in a middle-aged non-obese rural population: the chungju metabolic disease cohort (CMC) study,” Epidemiology and Health, vol. 33, Article ID e2011009, 2011.

J. O. Ebbert and M. D. Jensen, “Fat depots, free fatty acids, and dyslipidemia,” Nutrients, vol. 5, no. 2, pp. 498–508, 2013.

C. Syme, M. Abrahamowicz, G. T. Leonard et al., “Intra-abdominal adiposity and individual components of the metabolic syndrome in adolescence: sex differences and underlying mechanisms,” Archives of Pediatrics and Adolescent Medicine, vol. 162, no. 5, pp. 453–461, 2008.

C. Brufani, A. Tozzi, D. Fintini et al., “Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects,” European Journal of Endocrinology, vol. 160, no. 5, pp. 769–775, 2009.

W. Shen, M. Punyanitya, A. M. Silva et al., “Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study,” Nutrition and Metabolism, vol. 6, article 17, 2009.

K. N. Manolopoulos, F. Karpe, and K. N. Frayn, “Gluteofemoral body fat as a determinant of metabolic health,” International Journal of Obesity, vol. 34, no. 6, pp. 949–959, 2010.